CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives

Published:2022 Issue:7 Volume:12 Page:3329-3344
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

Chan Yau-Tuen,Lu Yuanjun,Wu Junyu,Zhang Cheng,Tan Hor-Yue,Bian Zhao-xiang,Wang Ning,Feng Yibin

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Writers, readers, and erasers RNA modifications and drug resistance in cancer;Molecular Cancer;2024-08-30

2. CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis;Journal of Experimental & Clinical Cancer Research;2024-08-29

3. Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy;Frontiers in Pharmacology;2024-07-25

4. Advances in Integrated Multi-omics Analysis for Drug-Target Identification;Biomolecules;2024-06-14

5. The Art of Finding the Right Drug Target: Emerging Methods and Strategies;Pharmacological Reviews;2024-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP